Jan 23 (Reuters) - ZEALAND PHARMA A/S:
* ZEALAND HAS COMPLETED A PHARMACOKINETIC (PK) STUDY WITH GLEPAGLUTIDE THAT CONFIRMS POTENTIAL FOR ONCE-WEEKLY DOSING
* ‍IS ON TRACK TO INITIATE PHASE 3 IN 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 